Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)

Oncogene

Volumn 24, Issue 3, 2005, Pages 344-354

  Yin, Dong ^a   Zhou, Hong ^a   Kumagai, Takashi ^a   Liu, Gentao ^a   Ong, John M ^a   Black, Keith L ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Glioblastoma multiforme; NF B; Proteasome inhibitor; PS 341

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BORTEZOMIB; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 5; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P27; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR E2F4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; BORONIC ACIDS; CELL DIVISION; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 13244262655     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208225     Document Type: Article

References (34)

1. Adams J, Palombella VJ and Elliott PJ. (2000). Invest. New Drugs, 18, 109-121.
2. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ. (1999). Cancer Res., 59, 2615-2622.
3. An J, Sun YP, Adams J, Fisher M, Belldegrun A and Rettig MB. (2003). Clin. Cancer Res., 9, 4537-4545.
4. Cusack JCJ, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J and Baldwin ASJ. (2001). Cancer Res., 61, 3535-3540.
5. Dai Y, Rahmani M and Grant S. (2003). Oncogene, 22, 7108-7122.
6. Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T and Hersey P. (2001). J. Immunol., 166, 5337-5345.
7. Frankel A, Man S, Elliott P, Adams J and Kerbel RS. (2000). Clin. Cancer Res., 6, 3719-3728.
8. Gallou C, Beroud C and Soussi T. (2001). http://p53.curie.fr.
9. Hayashi S, Yamamoto M, Ueno Y, Ikeda K, Ohshima K, Soma G and Fukushima T. (2001). Neurol. Med. Chir. (Tokyo), 41, 187-195.
10. Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, Hayashi T, Munshi N, Dang L, Castro A, Palombella V, Adams J and Anderson KC. (2002). J. Biol. Chem., 277, 16639-16647.
11. Hideshima T, Mitsiades C, Akiyama M, Hayashi T, Chauhan D, Richardson P, Schlossman R, Podar K, Munshi NC, Mitsiades N and Anderson KC. (2003). Blood, 101, 1530-1534.
12. Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J and Anderson KC. (2001). Cancer Res., 61, 3071-3076.
13. Imai Y, Strohmeyer TG, Fleishhacker M, Slamon DJ and Koeffler HP. (1994). Mod. Pathol., 7, 766-770.
14. Johnson TR, Stone K, Nikrad M, Yeh T, Zong WX, Thompson CB, Nesterov A and Kraft AS. (2003). Oncogene, 22, 4953-4963.
15. Kitagawa H, Tani E, Ikemoto H, Ozaki I, Nakano A and Omura S. (1999). FEBS Lett., 443, 181-186.
16. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
17. LeBlanc R, Catley LP, Hideshima T, Lentzsch S, Mitsiades CS, Mitsiades N, Neuberg D, Goloubeva O, Pien CS, Adams J, Gupta D, Richardson PG, Munshi NC and Anderson KC. (2002). Cancer Res., 62, 4996-5000.
18. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM and Perez-Soler R. (2003). Clin. Cancer Res., 9, 1145-1154.
19. Ling YH, Liebes L, Ng B, Buckley M, Elliott PJ, Adams J, Jiang JD, Muggia FM and Perez-Soler R. (2002). Mol. Cancer Ther., 1, 841-849.
20. Lopes UG, Erhardt P, Yao R and Cooper GM. (1997). J. Biol. Chem., 272, 12893-12896.
21. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Liberman TA, Treon SP, Munshi NC, Richardson PG, Hideshima T and Anderson KC. (2002). Proc. Natl. Acad. Sci. USA, 99, 14374-14379.
22. Munker R, Norman A and Koeffler HP. (1986). J. Clin. Invest., 78, 424-430.
23. Nagai S, Washiyama K, Kurimoto M, Takaku A, Endo S and Kumanishi T. (2002). J. Neurosurg. JID-0253357, 96, 909-917.
24. Nawrocki ST, Bruns CJ, Harbison MT, Bold RJ, Gotsch BS, Abbruzzese JL, Elliott P, Adams J and McConkey DJ. (2002). Mol. Cancer Ther., 1, 1243-1253.
25. Orlowski RZ, Stinchcombe TE, Mitchell BS, Shea TC, Baldwin AS, Stahl S, Adams J, Esseltine DL, Elliott PJ, Pien CS, Guerciolini R, Anderson JK, Depcik-Smith ND, Bhagat R, Lehman MJ, Novick SC, O'Connor OA and Soignet SL. (2002). J. Clin. Oncol., 20, 4420-4427.
26. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H and Kawashima S. (1996). Biochem. J., 317 (Part 2), 385-388.
27. Sunwoo JB, Chen Z, Dong G, Yeh N, Crowl BC, Sausville E, Adams J, Elliott P and Van Waes C. (2001). Clin. Cancer Res., 7, 1419-1428.
28. Tani E, Kitagawa H, Ikemoto H and Matsumoto T. (2001). FEBS Lett., 504, 53-58.
29. Teicher BA, Ara G, Herbst R, Palombella VJ and Adams J. (1999). Clin. Cancer Res., 5, 2638-2645.
30. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN. (1996). Nature, 380, 75-79.
31. Wagenknecht B, Hermisson M, Eitel K and Weller M. (1999). Cell Physiol. Biochem., 9, 117-125.
32. Wang CY, Mayo MW, Korneluk RG, Goeddel DV and Baldwin ASJ. (1998). Science, 281, 1680-1683.
33. Wu X and Levine AJ. (1994). Proc. Natl. Acad Sci. USA, 91, 3602-3606.
34. Yang Y, Ikezoe T, Saito T, Kobayashi M, Koeffler HP and Taguchi H. (2004). Cancer Sci., 95, 176-180.